With the UAE health authorities granting regulatory approval to Gilead Sciences to use remdesivir in COVID-19 patients, we take a closer look at its role in the recovery process.
In an exclusive interview with Dubai Eye on One, Frederico Silva, General Manager at Gilead for the Middle East region, explains what remdesivir actually does.
He also explained at what stage a COVID-19 patient should be given the drug.
Silva also touched upon the talks Gilead is having with the UAE Ministry of Health.
Talking about the pricing, he explained how Gilead has come up with two approaches - one for less developed countries and the second for developed nations.


UAE celebrates Flag Day today
UAE President holds bilateral talks with Bavarian Minister-President
Dubai expands flexible work options with first 'Work From Park' hub
Four UAE convoys enter Gaza Strip carrying 343 tonnes of aid
UAE launches AED12.5 million winter aid campaign to support 17 countries
